| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/24/1997 | EP0796335A1 Production of peptides using recombinant fusion protein constructs |
| 09/24/1997 | EP0796333A1 Glycoproteins from herpes virus and vaccines containing them |
| 09/24/1997 | EP0796332A1 Neisseria meningitidis subunit tbp2 |
| 09/24/1997 | EP0796331A2 Production and administration of high titer recombinant retroviruses |
| 09/24/1997 | EP0796330A1 Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
| 09/24/1997 | EP0796328A2 Protein detection |
| 09/24/1997 | EP0796326A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
| 09/24/1997 | EP0796325A1 Human vascular ibp-like growth factor |
| 09/24/1997 | EP0796321A1 E2 binding proteins |
| 09/24/1997 | EP0796280A2 Murine monoclonal anti-idiotype antibody 3h1 |
| 09/24/1997 | EP0796279A1 Antigen, antibodies and diagnostic assay for alzheimer's disease |
| 09/24/1997 | EP0796277A1 Reagents and processes for targeting mutant epidermal growth factor receptors |
| 09/24/1997 | EP0796276A1 Gradual modification, super-agonists and antagonists of signal-proteins and peptides |
| 09/24/1997 | EP0796275A2 Genes and gene products for use in the diagnosis of degenerative nerve damage |
| 09/24/1997 | EP0796274A2 Chromosome 21 gene marker, compositions and methods using same |
| 09/24/1997 | EP0796273A1 Variants of human papilloma virus antigens |
| 09/24/1997 | EP0796272A1 Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application |
| 09/24/1997 | EP0796269A1 Filtration |
| 09/24/1997 | EP0796113A2 Stable n-terminally linked dtpa:protein compositions and methods |
| 09/24/1997 | EP0796110A2 System for the maintenance, growth and differentiation of human and non-human primate pluripotent stem, progenitor and mature bone marrow cells |
| 09/24/1997 | EP0796106A1 Protracted glp-1 compositions |
| 09/24/1997 | EP0796104A1 Delivery of nucleic acid molecules to mucosal tissue |
| 09/24/1997 | EP0796101A1 Compositions and methods for inhibiting fungal cell wall formation |
| 09/24/1997 | EP0796088A1 Prevention of leakage during thermotropic phase transition in liposomes and biological cells |
| 09/24/1997 | EP0702794B1 Method and analytical device for simultaneous immunoassay |
| 09/24/1997 | EP0606463A4 Neuromedin b receptor antagonists. |
| 09/24/1997 | EP0563385B1 Thrombolytic peptide, production thereof and thrombolytic agent |
| 09/24/1997 | EP0521985B1 Chimeric antibodies with receptor binding ligands in place of their constant region |
| 09/24/1997 | CN1160420A Pesticidal proteins and strains |
| 09/24/1997 | CN1160081A Novel cell surface protein |
| 09/23/1997 | US5670690 Compositions and methods for removal of detergents |
| 09/23/1997 | US5670645 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies |
| 09/23/1997 | US5670637 Binding to target molecules; antibodies |
| 09/23/1997 | US5670635 Dna sequences |
| 09/23/1997 | US5670633 Sugar modified oligonucleotides that detect and modulate gene expression |
| 09/23/1997 | US5670630 Expression of hepatitis B S and preS2 proteins in methylotrophic |
| 09/23/1997 | US5670629 Ovoglycoprotein and agents for chromatographic separation containing same |
| 09/23/1997 | US5670627 Immunoassay |
| 09/23/1997 | US5670625 Cell surface protein |
| 09/23/1997 | US5670623 Methods of use of cellulose binding domain proteins |
| 09/23/1997 | US5670622 Conotoxin peptide PIIIA |
| 09/23/1997 | US5670621 Selectively recognizes and binds dna damaged by a drug |
| 09/23/1997 | US5670618 Isolated from saccharomyces |
| 09/23/1997 | US5670617 Nucleic acid conjugates of tat-derived transport polypeptides |
| 09/23/1997 | US5670616 Collagen-like polypeptides and biopolymers and nucleic acids encoding same |
| 09/23/1997 | US5670488 Adenovirus vector for gene therapy |
| 09/23/1997 | US5670483 Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| 09/23/1997 | US5670482 Neuropeptide Y antagonists |
| 09/23/1997 | US5670481 Dorsal tissue affecting factor (noggin) and compositions comprising same |
| 09/23/1997 | US5670479 α-ketoamide derivatives as inhibitors of thrombosis |
| 09/23/1997 | US5670373 Binding to human interleukin-6 receptors |
| 09/23/1997 | US5670371 Bacterial expression of superoxide dismutase |
| 09/23/1997 | US5670370 Replicon |
| 09/23/1997 | US5670369 Method for the production of soluble collagen |
| 09/23/1997 | US5670365 Isolated polynucleotide sequence |
| 09/23/1997 | US5670362 DNA encoding an Eimeria 100kD antigen |
| 09/23/1997 | US5670360 Nucleic acid dna with sequences and screening for agonists |
| 09/23/1997 | US5670354 Use of VSV-G pseudotyped vectors for transfer of genes into embryos |
| 09/23/1997 | US5670351 Methods and compositions for the ex vivo replication of human hematopoietic stem cells |
| 09/23/1997 | US5670350 Genomic DNA encoding a pseudomonas global transcriptional activation element and its use in activating gene expression |
| 09/23/1997 | US5670342 Stimulate the proliferation and differentiation of colon epithelial cells |
| 09/23/1997 | US5670341 DNA vectors, hosts, probes and recombinant methods of preparing human somatomedin-like carrier proteins or polypeptides |
| 09/23/1997 | US5670340 Process for producing peptides in E. coli |
| 09/23/1997 | US5670339 DNA encoding single chain monellin |
| 09/23/1997 | US5670338 Genetic engineering; therapy for osteoporosis |
| 09/23/1997 | US5670337 Polymorphism of human platelet membrane glycoprotein IIIa and diagnostic and therapeutic applications thereof |
| 09/23/1997 | US5670336 Method for recombinant production of osteogenic protein |
| 09/23/1997 | US5670335 Mammalian inward rectifier potasssium channel cDNAs, host cells expressing them, and screening assays using such cells |
| 09/23/1997 | US5670324 Use of chimeric CD4-src protein tyrosine kinases in drug screening and detection of an immune response |
| 09/23/1997 | US5670323 Process for the detection of malignant melanoma |
| 09/23/1997 | US5670319 Assay for tumor necrosis factor receptor-associated factors |
| 09/23/1997 | US5670311 Peptides for detecting antibodies to HTLV-2 |
| 09/23/1997 | US5670310 Methods and compositions for differential diagnosis of acute and chronic hepatitis c virus infection |
| 09/23/1997 | US5670309 Methods and diagnostic kits for the detections of HIV-2-specific antibodies employing polypeptides obtained from the simian immunodeficiency virus |
| 09/23/1997 | US5670155 Confomationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| 09/23/1997 | US5670153 Immunoreactive polypeptide compositions |
| 09/23/1997 | US5670152 Containing hepatitis virus epitopes |
| 09/23/1997 | US5670149 Lymphotoxin-β, Lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof |
| 09/23/1997 | US5670147 Compositions containing cultured mitotic human stem cells |
| 09/23/1997 | US5670146 Pharmacological preparations comprising human pluripotent hematopoietic colony stimulating factor |
| 09/23/1997 | US5670134 Method for evaluating and modifying biological activity |
| 09/23/1997 | US5670133 Chemotactic peptide containing labeled metal binding ions |
| 09/23/1997 | CA1339477C Gel filtration of factor viii |
| 09/23/1997 | CA1339468C Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same |
| 09/20/1997 | CA2200394A1 A pharmaceutical preparation for treating blood coagulation disorders |
| 09/18/1997 | WO1997034146A1 Inhibiting protein interactions |
| 09/18/1997 | WO1997034145A1 Antiphosphorylated tau protein antibody and method for detecting alzheimer's disease with the use of the same |
| 09/18/1997 | WO1997034015A1 Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays |
| 09/18/1997 | WO1997034013A1 Chemotactic cytokine ii |
| 09/18/1997 | WO1997034009A1 Recombinant adenoviral vectors for human tumour gene therapy |
| 09/18/1997 | WO1997034008A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 09/18/1997 | WO1997034002A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/18/1997 | WO1997034001A1 Clostridium perfringens vaccines |
| 09/18/1997 | WO1997034000A1 Expression and secretion of heterologous polypeptides from caulobacter |
| 09/18/1997 | WO1997033999A1 Immunity to trypanosomatids species |
| 09/18/1997 | WO1997033997A1 Method of treating muscular disorders |
| 09/18/1997 | WO1997033996A2 Human bikunin |
| 09/18/1997 | WO1997033995A2 Extracellular matrix signalling molecules |
| 09/18/1997 | WO1997033994A1 Use of viral cis-acting post-transcriptional regulatory sequences to increase expression of intronless genes containing near-consensus splice sites |
| 09/18/1997 | WO1997033993A1 Human membrane antigen tm4 superfamily protein and dna encoding this protein |